212 related articles for article (PubMed ID: 17233535)
1. Geldanamycin, an inhibitor of Hsp90, blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domains.
Kakar M; Kanwal C; Davis JR; Li H; Lim CS
AAPS J; 2006 Nov; 8(4):E718-28. PubMed ID: 17233535
[TBL] [Abstract][Full Text] [Related]
2. Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus.
Czar MJ; Galigniana MD; Silverstein AM; Pratt WB
Biochemistry; 1997 Jun; 36(25):7776-85. PubMed ID: 9201920
[TBL] [Abstract][Full Text] [Related]
3. Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90.
Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
Mol Cell Endocrinol; 2004 Jan; 213(2):131-8. PubMed ID: 15062560
[TBL] [Abstract][Full Text] [Related]
4. Assessment of glucocorticoid receptor-heat shock protein 90 interactions in vivo during nucleocytoplasmic trafficking.
Yang J; DeFranco DB
Mol Endocrinol; 1996 Jan; 10(1):3-13. PubMed ID: 8838140
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton.
Galigniana MD; Scruggs JL; Herrington J; Welsh MJ; Carter-Su C; Housley PR; Pratt WB
Mol Endocrinol; 1998 Dec; 12(12):1903-13. PubMed ID: 9849964
[TBL] [Abstract][Full Text] [Related]
6. Retrograde transport of the glucocorticoid receptor in neurites requires dynamic assembly of complexes with the protein chaperone hsp90 and is linked to the CHIP component of the machinery for proteasomal degradation.
Galigniana MD; Harrell JM; Housley PR; Patterson C; Fisher SK; Pratt WB
Brain Res Mol Brain Res; 2004 Apr; 123(1-2):27-36. PubMed ID: 15046863
[TBL] [Abstract][Full Text] [Related]
7. Separable features of the ligand-binding domain determine the differential subcellular localization and ligand-binding specificity of glucocorticoid receptor and progesterone receptor.
Wan Y; Coxe KK; Thackray VG; Housley PR; Nordeen SK
Mol Endocrinol; 2001 Jan; 15(1):17-31. PubMed ID: 11145736
[TBL] [Abstract][Full Text] [Related]
8. Differential alteration of heat shock protein 90 in mice modifies glucocorticoid receptor function and susceptibility to trauma.
Shen HY; Zhao Y; Chen XY; Xiong RP; Lu JL; Chen JF; Chen LY; Zhou YG
J Neurotrauma; 2010 Feb; 27(2):373-81. PubMed ID: 19845467
[TBL] [Abstract][Full Text] [Related]
9. A ligand-specific kinetic switch regulates glucocorticoid receptor trafficking and function.
Trebble PJ; Woolven JM; Saunders KA; Simpson KD; Farrow SN; Matthews LC; Ray DW
J Cell Sci; 2013 Jul; 126(Pt 14):3159-69. PubMed ID: 23687373
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds.
Prima V; Depoix C; Masselot B; Formstecher P; Lefebvre P
J Steroid Biochem Mol Biol; 2000; 72(1-2):1-12. PubMed ID: 10731632
[TBL] [Abstract][Full Text] [Related]
11. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells.
Whitesell L; Cook P
Mol Endocrinol; 1996 Jun; 10(6):705-12. PubMed ID: 8776730
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the glucocorticoid receptor assembly with heat shock protein 90 by a peptidic antiglucocorticoid.
Dao-Phan HP; Formstecher P; Lefebvre P
Mol Endocrinol; 1997 Jun; 11(7):962-72. PubMed ID: 9178755
[TBL] [Abstract][Full Text] [Related]
13. The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation.
Rosenhagen MC; Sōti C; Schmidt U; Wochnik GM; Hartl FU; Holsboer F; Young JC; Rein T
Mol Endocrinol; 2003 Oct; 17(10):1991-2001. PubMed ID: 12869591
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 90 is an essential molecular chaperone for nuclear transport of glucocorticoid receptor beta.
Zhang X; Clark AF; Yorio T
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):700-8. PubMed ID: 16431970
[TBL] [Abstract][Full Text] [Related]
15. Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.
Bagatell R; Khan O; Paine-Murrieta G; Taylor CW; Akinaga S; Whitesell L
Clin Cancer Res; 2001 Jul; 7(7):2076-84. PubMed ID: 11448926
[TBL] [Abstract][Full Text] [Related]
16. Chromatin recycling of glucocorticoid receptors: implications for multiple roles of heat shock protein 90.
Liu J; DeFranco DB
Mol Endocrinol; 1999 Mar; 13(3):355-65. PubMed ID: 10076993
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin.
Bamberger CM; Wald M; Bamberger AM; Schulte HM
Mol Cell Endocrinol; 1997 Aug; 131(2):233-40. PubMed ID: 9296382
[TBL] [Abstract][Full Text] [Related]
18. The function of steroid hormone receptors is inhibited by the hsp90-specific compound geldanamycin.
Segnitz B; Gehring U
J Biol Chem; 1997 Jul; 272(30):18694-701. PubMed ID: 9228040
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
20. Effects of heat shock protein 90 expression on pectoralis major oxidation in broilers exposed to acute heat stress.
Hao Y; Gu XH
Poult Sci; 2014 Nov; 93(11):2709-17. PubMed ID: 25239533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
